En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

Sep 2013 Oncoimmunology

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation.


Gertner-Dardenne J, Fauriat C, Olive D


Although in the last few years γδ T lymphocytes have been the subject of growing interest as potential anticancer immunotherapeutics, how the proliferative and effector responses of these cells are regulated remains unclear. We have recently reported that the co-receptor B and T lymphocyte associated (BTLA) inhibits the proliferation of human Vγ9Vδ2 T cells, potentially underpinning a mechanism of immune escape by lymphoma cells.

Lire l‘article